Lixte Biotechnology LIXT
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2025Q3 | 5.03 | 5 | -71.18 | -2 | -59.79 | 5 |
| 2025Q2 | 0.91 | 1 | -85.75 | -1 | -57.42 | 1 |
| 2025Q1 | 1.21 | 1 | -71.50 | -1 | -53.38 | 2 |
| 2024Q4 | 2.03 | 1 | -56.34 | -1 | -43.49 | 1 |
| 2024Q3 | 1.87 | 1 | -54.58 | -1 | -45.19 | 2 |
| 2024Q2 | 2.37 | 2 | -37.64 | -1 | -32.32 | 3 |
| 2024Q1 | 3.38 | 3 | -27.27 | -1 | -24.59 | 4 |
| 2023Q4 | 2.35 | 4 | -23.14 | -1 | -21.63 | 4 |
| 2023Q3 | 2.45 | 5 | -26.76 | -1 | -24.47 | 5 |
| 2023Q2 | 5.88 | 3 | -49.25 | -2 | -44.92 | 3 |
| 2023Q1 | 8.27 | 4 | -29.59 | -1 | -27.66 | 4 |
| 2022Q4 | 5.09 | 5 | -28.18 | -2 | -26.35 | 6 |
| 2022Q3 | 5.60 | 6 | -21.26 | -1 | -19.92 | 7 |
| 2022Q2 | 7.45 | 7 | -28.20 | -2 | -25.47 | 8 |
| 2022Q1 | 12.30 | 3 | -40.11 | -2 | -35.98 | 4 |
| 2021Q4 | 11.90 | 5 | -37.35 | -2 | -35.51 | 5 |
| 2021Q3 | 20.80 | 6 | -19.15 | -1 | -18.25 | 6 |
| 2021Q2 | 30.30 | 7 | -23.88 | -2 | -22.90 | 7 |
| 2021Q1 | 32.90 | 8 | -27.28 | -2 | -26.33 | 8 |
| 2020Q4 | 31.70 | 5 | -29.48 | -1 | -27.53 | 5 |